{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:00:52Z","timestamp":1776294052865,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.suc.2025.12.011","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:43:43Z","timestamp":1770381823000},"page":"213-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucagon-like Peptide-1 Receptor Agonists"],"prefix":"10.1016","volume":"106","author":[{"given":"Mark","family":"Kligman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Holsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.suc.2025.12.011_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1378\/chest.09-1737","article-title":"Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis","volume":"137","author":"Marik","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.suc.2025.12.011_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamasurg.2021.5561","article-title":"Paradoxical association of hyperglycemia and surgical complications among patients with and without diabetes","volume":"157","author":"Chen","year":"2022","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.suc.2025.12.011_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70015","article-title":"Chronic glycemic control influences the relationship between acute perioperative dysglycemia and perioperative outcome","volume":"16","author":"Stretton","year":"2024","journal-title":"J Diabetes"},{"issue":"9","key":"10.1016\/j.suc.2025.12.011_bib4","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1002\/jhm.533","article-title":"Inpatient glucose control: a glycemic survey of 126 U.S. hospitals","volume":"4","author":"Cook","year":"2009","journal-title":"J Hosp Med"},{"issue":"1","key":"10.1016\/j.suc.2025.12.011_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/aas.70149","article-title":"Incidence and predictors of dysglycemia in intensive care unit patients: a cohort study","volume":"70","author":"Gantzel","year":"2026","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"10.1016\/j.suc.2025.12.011_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","article-title":"Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting","volume":"125","author":"Furnary","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.suc.2025.12.011_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.surg.2019.02.022","article-title":"Glycemic variability and mortality in patients hospitalized in general surgery wards","volume":"166","author":"Akirov","year":"2019","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.suc.2025.12.011_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00592-020-01493-w","article-title":"The prognostic role of peak glycemia and glucose variability in trauma: a single-center investigation","volume":"57","author":"Lazzeri","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.suc.2025.12.011_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114390","article-title":"GLP-1 as a regulator of sepsis outcomes: insights into cellular metabolism, inflammation, and therapeutic potential","volume":"152","author":"Fan","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.suc.2025.12.011_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","article-title":"Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers","volume":"87","author":"Nauck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.suc.2025.12.011_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bph.15485","article-title":"Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands","volume":"179","author":"Tanday","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.suc.2025.12.011_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3390\/jcm13051347","article-title":"Physiological appetite regulation and bariatric surgery","volume":"13","author":"Ramasamy","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.suc.2025.12.011_bib13","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/cc7874","article-title":"The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study","volume":"13","author":"Deane","year":"2009","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.suc.2025.12.011_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/cc9983","article-title":"Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes","volume":"15","author":"Deane","year":"2011","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.suc.2025.12.011_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4103\/ijccm.IJCCM_105_17","article-title":"Liraglutide as an alternative to insulin for glycemic control in intensive care unit: a randomized, open-label, clinical study","volume":"21","author":"Verma","year":"2017","journal-title":"Indian J Crit Care Med"},{"issue":"12","key":"10.1016\/j.suc.2025.12.011_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/dom.13029","article-title":"Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: a single-blind, randomized controlled trial","volume":"19","author":"Lip\u0161","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.suc.2025.12.011_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12933-018-0784-y","article-title":"Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II\/III ExSTRESS randomized trial","volume":"17","author":"Besch","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.suc.2025.12.011_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.suc.2025.12.011_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.suc.2025.12.011_bib20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.suc.2025.12.011_bib21","article-title":"GLP-1 receptor: a new target for sepsis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.suc.2025.12.011_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027712","article-title":"GLP-1 promotes cortical and medullary perfusion in the human kidney and maintains renal oxygenation during NaCl loading","volume":"12","author":"Haddock","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.suc.2025.12.011_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.738848","article-title":"Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system","volume":"12","author":"Puglisi","year":"2021","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.suc.2025.12.011_bib24","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehae613","article-title":"Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial","volume":"46","author":"Mahaffey","year":"2025","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.suc.2025.12.011_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.suc.2025.12.011_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MNH.0000000000001066","article-title":"Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond","volume":"34","author":"Faruque","year":"2025","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"10.1016\/j.suc.2025.12.011_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pharep.2015.10.008","article-title":"Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes\/macrophages in a protein kinase A and B\/Akt manner","volume":"68","author":"Bu\u0142dak","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.suc.2025.12.011_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41374-018-0170-0","article-title":"Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function","volume":"99","author":"Xu","year":"2019","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.suc.2025.12.011_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SHK.0000000000002285","article-title":"Liraglutide alleviates acute lung injury and mortality in pneumonia-induced sepsis through regulating surfactant protein expression and secretion","volume":"61","author":"Guo","year":"2024","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.suc.2025.12.011_bib30","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bph.13549","article-title":"Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice","volume":"174","author":"Steven","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.suc.2025.12.011_bib31","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.3390\/ijms25094900","article-title":"Peptides are cardioprotective drugs of the future: the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like peptide-1 receptor agonists","volume":"25","author":"Boshchenko","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.suc.2025.12.011_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/ALN.0000000000001838","article-title":"Clinical effectiveness of intravenous exenatide infusion in perioperative glycemic control after coronary artery bypass graft surgery: a phase II\/III randomized trial","volume":"127","author":"Besch","year":"2017","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.suc.2025.12.011_bib33","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2025.12.011_bib34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.suc.2025.12.011_bib35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.gie.2024.12.019","article-title":"Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis","volume":"101","author":"Baig","year":"2025","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.suc.2025.12.011_bib36","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.suc.2025.12.011_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080340","article-title":"Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study","volume":"387","author":"Alkabbani","year":"2024","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.suc.2025.12.011_bib38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/anae.16601","article-title":"Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis","volume":"80","author":"Elkin","year":"2025","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.suc.2025.12.011_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bja.2025.04.001","article-title":"Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: society for perioperative assessment and quality improvement (SPAQI) multidisciplinary consensus statement","volume":"135","author":"Oprea","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.suc.2025.12.011_bib40","article-title":"Assessment of gastric content using gastric ultrasound in patients on glucagon-like peptide-1 receptor agonists before anesthesia","author":"Pai","year":"2025","journal-title":"Anesth Analg"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610925001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610925001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:04:16Z","timestamp":1776290656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610925001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0039610925001409"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2025.12.011","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like Peptide-1 Receptor Agonists","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2025.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}